Structure of the envelope glycoprotein (Env) from HIV Clade C

Ian Wilson group (The Scripps Research Institute) and collaborators

 

Throughout the world, HIV occurs in different strains or clades, each with a distinct variant of the surface glycoprotein (Env), which is the sole neutralization target of antibodies. Env forms a heavily glycosylated trimer of gp120/gp41 heterodimers that facilitates fusion of the virus membrane and the host cell membrane. In 2013, using data collected at GM/CA beamlines, Wilson's group published the structure of the envelope glycoprotein (Env) from Clade A. However, Clade C is responsible for the majority of infections worldwide, but Env from Clade C is notoriously unstable. Recently, using glycine substitutions to stabilize the pre-fusion state and data from multiple crystals, Wilson's group and collaborators determined the structure of Clade C Env to 3.9-Angstrom resolution. The structure led to the design of cross-clade immunogens, which in additional studies were shown to illicit neutralizing antibodies in non-human primates, and may lead to an effective vaccine for humans.

Figure: Structure of Env trimer from HIV Clade C.

 

Citation: Guenaga J, Garces F, de Val N, Stanfield RL, Dubrovskaya V, Higgins B, Carrette B, Ward AB, Wilson IA, Wyatt RT, Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein, Immunity 46, 792 (May 16, 2017). DOI: 10.1016/j.immuni.2017.04.014

 

 


GM/CA @ APS Sponsors: National Institute of General Medical Sciences (NIGMS) and National Cancer Institute (NCI) of the National Institutes of Health (NIH).

  APS is an Office of Science User Facility operated for the U.S. Department of Energy by Argonne National Laboratory

  UChicago Argonne LLC | Privacy & Security Notice | Contact Us | A-Z Index | Search